Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9616)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Oct 28, 2015 (publication date) through May 6, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Takedatsu H, Mitsuyama K, Torimura T. Nanomedicine and drug delivery strategies for treatment of inflammatory bowel disease. World J Gastroenterol 2015; 21(40): 11343-11352 [PMID: 26525603 DOI: 10.3748/wjg.v21.i40.11343] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i40/11343.htm |
| Number | Citing Articles |
| 1 |
Xiaoxian Wang, Si Li, Xin Liu, Xian Wu, Ningbing Ye, Xiangliang Yang, Zifu Li. Bio-Nanomedicine for Cancer Therapy. Advances in Experimental Medicine and Biology 2021; 1295: 77 doi: 10.1007/978-3-030-58174-9_4
|
| 2 |
Amandeep Singh, Kirandeep Kaur, Uttam Kumar Mandal, Raj Kumar Narang. Nanoparticles as Budding Trends in Colon Drug Delivery for the Management of Ulcerative Colitis. Current Nanomedicine 2020; 10(3): 225 doi: 10.2174/2468187310999200621200615
|
| 3 |
Maricla Galetti, Stefano Rossi, Cristina Caffarra, Amparo Guerrero Gerboles, Michele Miragoli. Exposure to Engineered Nanomaterials in the Environment. 2019; : 235 doi: 10.1016/B978-0-12-814835-8.00009-1
|
| 4 |
Daniela Placha, Josef Jampilek. Chronic Inflammatory Diseases, Anti-Inflammatory Agents and Their Delivery Nanosystems. Pharmaceutics 2021; 13(1): 64 doi: 10.3390/pharmaceutics13010064
|
| 5 |
Bojan Čalija, Jela Milić. Targeted delivery of anti-inflammatory drugs in lower parts of gastrointestinal tract: Conventional and novel approaches. Arhiv za farmaciju 2017; 67(3): 124 doi: 10.5937/arhfarm1702124C
|
| 6 |
Lauren J. Mohan, Jacqueline S. Daly, Barbara M. Ryan, Zebunnissa Ramtoola. The future of nanomedicine in optimising the treatment of inflammatory bowel disease. Scandinavian Journal of Gastroenterology 2019; 54(1): 18 doi: 10.1080/00365521.2018.1563805
|
| 7 |
Chenxi Huang, Jian Xu, Jing Li, Siyu He, Huipeng Xu, Xiaohong Ren, Vikramjeet Singh, Li Wu, Jiwen Zhang. Hydrogen peroxide responsive covalent cyclodextrin framework for targeted therapy of inflammatory bowel disease. Carbohydrate Polymers 2022; 285: 119252 doi: 10.1016/j.carbpol.2022.119252
|
| 8 |
Ying Cai, Luoxin Zhang, Youjian Zhang, Rong Lu. Plant-Derived Exosomes as a Drug-Delivery Approach for the Treatment of Inflammatory Bowel Disease and Colitis-Associated Cancer. Pharmaceutics 2022; 14(4): 822 doi: 10.3390/pharmaceutics14040822
|
| 9 |
Fanny Giron, Anna Pastó, Ennio Tasciotti, Bincy P Abraham. Nanotechnology in the Treatment of Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2019; 25(12): 1871 doi: 10.1093/ibd/izz205
|
| 10 |
Tamara G. Dacoba, Ana Olivera, Dolores Torres, José Crecente-Campo, María José Alonso. Modulating the immune system through nanotechnology. Seminars in Immunology 2017; 34: 78 doi: 10.1016/j.smim.2017.09.007
|
| 11 |
Markus Ries, Brice Moulari, Maryam A. Shetab Boushehri, Mohamed Ehab Ali, Daniel Molnar, Arnaud Béduneau, Yann Pellequer, Alf Lamprecht. Adalimumab Decorated Nanoparticles Enhance Antibody Stability and Therapeutic Outcome in Epithelial Colitis Targeting. Pharmaceutics 2022; 14(2): 352 doi: 10.3390/pharmaceutics14020352
|
| 12 |
Deenaz Zaidi, Eytan Wine. Regulation of Nuclear Factor Kappa-Light-Chain-Enhancer of Activated B Cells (NF-κβ) in Inflammatory Bowel Diseases. Frontiers in Pediatrics 2018; 6 doi: 10.3389/fped.2018.00317
|
| 13 |
Hong Yang, Lisa Kozicky, Aabida Saferali, Shan-Yu Fung, Nicole Afacan, Bing Cai, Reza Falsafi, Erin Gill, Mingyao Liu, Tobias R. Kollmann, R.E.W. Hancock, Laura M. Sly, Stuart E. Turvey. Endosomal pH modulation by peptide-gold nanoparticle hybrids enables potent anti-inflammatory activity in phagocytic immune cells. Biomaterials 2016; 111: 90 doi: 10.1016/j.biomaterials.2016.09.032
|
| 14 |
Chau T. H. Nguyen, Richard I. Webb, Lynette K. Lambert, Ekaterina Strounina, Edward C. Lee, Marie-Odile Parat, Michael A. McGuckin, Amirali Popat, Peter J. Cabot, Benjamin P. Ross. Bifunctional Succinylated ε-Polylysine-Coated Mesoporous Silica Nanoparticles for pH-Responsive and Intracellular Drug Delivery Targeting the Colon. ACS Applied Materials & Interfaces 2017; 9(11): 9470 doi: 10.1021/acsami.7b00411
|
| 15 |
Andreea Nedelcu, Ofelia Mosteanu, Teodora Pop, Teodora Mocan, Lucian Mocan. Recent Advances in Nanoparticle-Mediated Treatment of Inflammatory Bowel Diseases. Applied Sciences 2021; 11(1): 438 doi: 10.3390/app11010438
|
| 16 |
Chandrashekhar Jori, Anis Ahmad Chaudhary, Summya Rashid, Mohamed A. M. Ali, Abdullah S. Alawam, Faouzi Haouala, Rehan Khan. Biomaterial-based strategies for immunomodulation in IBD: current and future scenarios. Journal of Materials Chemistry B 2023; 11(25): 5668 doi: 10.1039/D3TB00276D
|
| 17 |
Meng Yan, Li Zhu, Shuai Wu, Yu Cao, Nianlian Mou, Qingjia Chi, Guixue Wang, Yuan Zhong, Wei Wu. ROS responsive polydopamine nanoparticles to relieve oxidative stress and inflammation for ameliorating acute inflammatory bowel. Biomaterials Advances 2022; 142: 213126 doi: 10.1016/j.bioadv.2022.213126
|
| 18 |
Paul D. Acton. Image Fusion in Preclinical Applications. 2019; : 135 doi: 10.1007/978-3-030-02973-9_7
|
| 19 |
Jinlin Liu, Yanxia Chen, Dongsheng Liu, Wei Liu, Sijun Hu, Nanjin Zhou, Yong Xie. Ectopic expression of SIGIRR in the colon ameliorates colitis in mice by downregulating TLR4/NF-κB overactivation. Immunology Letters 2017; 183: 52 doi: 10.1016/j.imlet.2017.01.015
|
| 20 |
Yilin Guo, Shiyu Zong, Yiqiong Pu, Benliang Xu, Tong Zhang, Bing Wang. Advances in Pharmaceutical Strategies Enhancing the Efficiencies of Oral Colon-Targeted Delivery Systems in Inflammatory Bowel Disease. Molecules 2018; 23(7): 1622 doi: 10.3390/molecules23071622
|
| 21 |
Ruifeng Luo, Meisi Lin, Chen Zhang, Jinfeng Shi, Siyuan Zhang, Qiyan Chen, Yichen Hu, Minyue Zhang, Jinming Zhang, Fei Gao. Genipin-crosslinked human serum albumin coating using a tannic acid layer for enhanced oral administration of curcumin in the treatment of ulcerative colitis. Food Chemistry 2020; 330: 127241 doi: 10.1016/j.foodchem.2020.127241
|
| 22 |
Tolulope O. Ajala, Abraham Abraham, Cornelia M. Keck, Oluwatoyin A. Odeku, Taiwo O. Elufioye, James O. Olopade. Shea butter (Vitellaria paradoxa) and Pentaclethra macrophylla oil as lipids in the formulation of Nanostructured lipid carriers. Scientific African 2021; 13: e00965 doi: 10.1016/j.sciaf.2021.e00965
|
| 23 |
Jingjing Jiang, Jingcheng Xiao, Zexu Zhao, Mao-Sen Yuan, Jinyi Wang. One-step prepared nano-in-micro microcapsule delivery vehicle with sequential burst–sustained drug release for the targeted treatment of inflammatory bowel disease. Materials Chemistry Frontiers 2021; 5(16): 6027 doi: 10.1039/D1QM00589H
|
| 24 |
Herve Courthion, Thibault Mugnier, Christel Rousseaux, Michael Möller, Robert Gurny, Doris Gabriel. Self-assembling polymeric nanocarriers to target inflammatory lesions in ulcerative colitis. Journal of Controlled Release 2018; 275: 32 doi: 10.1016/j.jconrel.2017.07.044
|
| 25 |
Vincent Lenders, Xanthippi Koutsoumpou, Philana Phan, Stefaan J. Soenen, Karel Allegaert, Steven de Vleeschouwer, Jaan Toelen, Zongmin Zhao, Bella B. Manshian. Modulation of engineered nanomaterial interactions with organ barriers for enhanced drug transport. Chemical Society Reviews 2023; 52(14): 4672 doi: 10.1039/D1CS00574J
|
| 26 |
Hisako Ibaraki, Naruhiro Hatakeyama, Naoki Arima, Akihiro Takeda, Yasuo Seta, Takanori Kanazawa. Systemic delivery of siRNA to the colon using peptide modified PEG-PCL polymer micelles for the treatment of ulcerative colitis. European Journal of Pharmaceutics and Biopharmaceutics 2022; 170: 170 doi: 10.1016/j.ejpb.2021.12.009
|
| 27 |
Sufeng Zhang, Won Joon Cho, Amy T. Jin, Lie Yun Kok, Yunhua Shi, David E. Heller, Young‐Ah Lucy Lee, Yixuan Zhou, Xi Xie, Joshua R. Korzenik, Jochen K. Lennerz, Giovanni Traverso. Heparin‐Coated Albumin Nanoparticles for Drug Combination in Targeting Inflamed Intestine. Advanced Healthcare Materials 2020; 9(16) doi: 10.1002/adhm.202000536
|
| 28 |
Chiara Dianzani, Federica Foglietta, Benedetta Ferrara, Arianna Carolina Rosa, Elisabetta Muntoni, Paolo Gasco, Carlo Della Pepa, Roberto Canaparo, Loredana Serpe. Solid lipid nanoparticles delivering anti-inflammatory drugs to treat inflammatory bowel disease: Effects in an <i>in vivo</i> model. World Journal of Gastroenterology 2017; 23(23): 4200-4210 doi: 10.3748/wjg.v23.i23.4200
|
| 29 |
Tamara Pérez-Jeldres, Christopher J Tyler, Joshua D Boyer, Thangaraj Karuppuchamy, Giorgos Bamias, Parambir S Dulai, Brigid S Boland, William J Sandborn, Derek R Patel, Jesús Rivera-Nieves. Cell Trafficking Interference in Inflammatory Bowel Disease: Therapeutic Interventions Based on Basic Pathogenesis Concepts. Inflammatory Bowel Diseases 2019; 25(2): 270 doi: 10.1093/ibd/izy269
|
| 30 |
Runxin Xu, Marie-Christin Weber, Xinkai Hu, Philipp-Alexander Neumann, Nazila Kamaly. Annexin A1 based inflammation resolving mediators and nanomedicines for inflammatory bowel disease therapy. Seminars in Immunology 2022; : 101664 doi: 10.1016/j.smim.2022.101664
|
| 31 |
Cintia M. S. Cereda, Giovana R. Tofoli. Biotechnology Applied to Inflammatory Diseases. Interdisciplinary Biotechnological Advances 2023; : 287 doi: 10.1007/978-981-19-8342-9_13
|
| 32 |
Qing Li, Ying Liu, Xianglin Dai, Wei Jiang, Huan Zhao. Nanozymes Regulate Redox Homeostasis in ROS-Related Inflammation. Frontiers in Chemistry 2021; 9 doi: 10.3389/fchem.2021.740607
|
| 33 |
Jorge O. Avila-Alejo, Ana K. González-Palomo, Germán Plascencia-Villa, Miguel José-Yacamán, Hugo R. Navarro-Contreras, Iván N. Pérez-Maldonado. Low cytotoxicity of anisotropic gold nanoparticles coated with lysine on peripheral blood mononuclear cells “in vitro”. Environmental Toxicology and Pharmacology 2017; 56: 210 doi: 10.1016/j.etap.2017.09.014
|
| 34 |
Sourav Bhattacharjee. DLS and zeta potential – What they are and what they are not?. Journal of Controlled Release 2016; 235: 337 doi: 10.1016/j.jconrel.2016.06.017
|
| 35 |
Rohitas Deshmukh, Ranjit K. Harwansh, Swarnali Das Paul, Rishikesh Shukla. Controlled release of sulfasalazine loaded amidated pectin microparticles through Eudragit S 100 coated capsule for management of inflammatory bowel disease. Journal of Drug Delivery Science and Technology 2020; 55: 101495 doi: 10.1016/j.jddst.2019.101495
|